Bruker Stock (NASDAQ:BRKR)



Previous Close

$40.45

52W Range

$34.10 - $72.94

50D Avg

$39.46

200D Avg

$48.89

Market Cap

$6.36B

Avg Vol (3M)

$2.67M

Beta

1.18

Div Yield

$0.20 (0.48%)

BRKR Company Profile


Bruker Corporation develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions in the United States and internationally. The company operates through three segments: Bruker Scientific Instruments (BSI) Life Science, BSI NANO, and Bruker Energy & Supercon Technologies. It offers life science tools, and single and multiple modality systems; life science mass spectrometry; MALDI Biotyper rapid pathogen identification platform and related test kits, DNA test strips, and fluorescence-based polymerase chain reaction technology; genotype and fluorotype molecular diagnostics kits; research, analytical, and process analysis instruments and solutions; SARS-CoV 2 testing for the diagnosis of COVID-19 infection; and Fluorotyper-SARS-CoV 2 plus kits. It also provides range of portable analytical and bioanalytical detection systems, and related products; X-ray instruments; analytical tools for electron microscopes, as well as handheld, portable, and mobile X-ray fluorescence spectrometry instruments; atomic force microscopy instrumentation; non-contact nanometer resolution solution topography; and automated X-ray metrology, automated AFM defect-detection, and photomask repair and cleaning equipment. In addition, the company offers advanced optical fluorescence microscopy instruments; products and services to support the multi-omics needs of researchers in translational research, drug, and biomarker discovery; superconducting materials, such as metallic low temperature superconductors; devices and complex tools based on metallic low temperature superconductors; and non-superconducting high technology tools, such as synchrotron and beamline instrumentation. Bruker Corporation has a collaboration with Newomics Inc. on a LC-MS platform for drug discovery. The company was incorporated in 1991 and is headquartered in Billerica, Massachusetts.

Industry

Medical - Devices

Sector

Healthcare

Exchange

NASDAQ

ADR

-

Country

US

Employees

11,396

IPO Date

Aug 04, 2000

Website

BRKR Performance


Latest Earnings Call Transcripts


Q2 22Aug 03, 22 | 11:31 PM
Q1 22May 04, 22 | 1:52 PM
Q4 21Feb 11, 22 | 2:09 PM

Peer Comparison


TickerCompany
CNMDCONMED Corporation
CRLCharles River Laboratories International, Inc.
ITGRInteger Holdings Corporation
STESTERIS plc
ANIKAnika Therapeutics, Inc.
GKOSGlaukos Corporation
MTDMettler-Toledo International Inc.
ICLRICON Public Limited Company
BIOBio-Rad Laboratories, Inc.
WATWaters Corporation